EUVIMEDEUVIMED entdecken
Open Access

Aprepitant’s neuroprotective effects on methylphenidate-induced biochemical/mitochondrial dysfunction, neuroinflammation, and mood-related behavior alterations

Ladan Akbarpournikghalb, Parisa Pourdehghan Shahrestani, Mahnaz Gomi, A Wallace Hayes, Mahdieh Gholami, Majid Motaghinejad

DARU Journal of Pharmaceutical Sciences · 24.06.2026 · 34 (2)

DOI: 10.1007/s40199-026-00610-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DARU Journal of Pharmaceutical Sciences, online erschienen am 24.06.2026. Verfasst von Ladan Akbarpournikghalb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Methylphenidate, Neuroprotective Agents, Mitochondria, Aprepitant. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic methylphenidate (MPH) use causes neurological and behavioral problems. Aprepitant (APR) has demonstrated neuroprotective effects. OBJECTIVES: This research investigated APR's neuroprotective effects against MPH-induced biochemical, mitochondrial, motor, and mood disturbances in rats. METHOD: Forty-eight male Wistar rats were divided into six groups to receive treatment for 21 days with saline, MPH, or different doses of APR combined with MPH. Behavioral tests included OFT, EPM, and FST; biochemical assessments focused on hippocampal inflammation, oxidative stress, and apoptosis pathways. RESULTS: APR dose-dependently mitigated the MPH-induced disruptions in motor activity and mood, and increased activities of glutathione peroxidase (GPx), glutathione reductase (GR), and superoxide dismutase (SOD), along with levels of mitochondrial membrane potential (ΔΨm = MMP), reduced glutathione (GSH), total antioxidant capacity (TAC), adenosine triphosphate (ATP), and unphosphorylated Bcl-2. In MPH-treated rats, APR decreased tumor necrosis factor-α (TNF-α), interleukin-1 beta (IL-1β), oxidized glutathione (GSSG), reactive oxygen species (ROS), malondialdehyde (MDA), and hydrogen peroxide (H2O2), and reduced both forms of JNK, Bax, Beclin-1, and phosphorylated Bcl-2. CONCLUSION: APR dose-dependently alleviated MPH-induced anxiety and depression-like behaviors, restored redox and mitochondrial homeostasis, suppressed MPH-induced neuroinflammation and neuronal apoptosis, and influenced Beclin, a key regulator of autophagosome nucleation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylphenidateNeuroprotective AgentsMitochondriaAprepitantNeuroinflammatory DiseasesAnimalsMaleRats, WistarRatsOxidative StressBehavior, AnimalApoptosisHippocampusMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

AprepitantMethylphenidateMitochondrial dysfunctionNeuro-inflammationRedox system

Substanzen

MethylphenidateNeuroprotective AgentsAprepitant

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Pediatric Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Institute for Integrative Toxicology, Michigan State UniversityEast Lansing, Florida, MI, USA.
  • Department of pharmacy, Alma master studiorum university of Bologna, Bologna, Italia.
  • Pediatric Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. dr.motaghinejad6@gmail.com.

Zitieren

APA

Akbarpournikghalb, L., Pourdehghan Shahrestani, P., Gomi, M., Hayes, A. W., Gholami, M., & Motaghinejad, M. (2026). Aprepitant’s neuroprotective effects on methylphenidate-induced biochemical/mitochondrial dysfunction, neuroinflammation, and mood-related behavior alterations. DARU Journal of Pharmaceutical Sciences, 34(2). https://doi.org/10.1007/s40199-026-00610-4

Vancouver

Akbarpournikghalb L, Pourdehghan Shahrestani P, Gomi M, Hayes AW, Gholami M, Motaghinejad M. Aprepitant’s neuroprotective effects on methylphenidate-induced biochemical/mitochondrial dysfunction, neuroinflammation, and mood-related behavior alterations. DARU Journal of Pharmaceutical Sciences. 2026;34(2). doi:10.1007/s40199-026-00610-4

BibTeX
@article{Akbarpournikghalb2026,
  author = {Akbarpournikghalb, Ladan and Pourdehghan Shahrestani, Parisa and Gomi, Mahnaz and Hayes, A Wallace and Gholami, Mahdieh and Motaghinejad, Majid},
  title = {Aprepitant’s neuroprotective effects on methylphenidate-induced biochemical/mitochondrial dysfunction, neuroinflammation, and mood-related behavior alterations},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {34},
  number = {2},
  doi = {10.1007/s40199-026-00610-4}
}
Kostenlos starten →